A

Aurisco Pharmaceutical Co Ltd
SSE:605116

Watchlist Manager
Aurisco Pharmaceutical Co Ltd
SSE:605116
Watchlist
Price: 21.12 CNY -4.91% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Aurisco Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Aurisco Pharmaceutical Co Ltd

Current Assets 1.4B
Cash & Short-Term Investments 435.3m
Receivables 378.6m
Other Current Assets 570.5m
Non-Current Assets 1.5B
Long-Term Investments 79.3m
PP&E 1.3B
Intangibles 120m
Other Non-Current Assets 21.6m
Current Liabilities 622.9m
Accounts Payable 245.3m
Accrued Liabilities 37.4m
Short-Term Debt 215.5m
Other Current Liabilities 124.6m
Non-Current Liabilities 166.7m
Long-Term Debt 130.6m
Other Non-Current Liabilities 36.1m

Balance Sheet
Aurisco Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
195
167
259
560
445
392
535
Cash
0
0
0
0
440
340
534
Cash Equivalents
195
167
259
560
4
52
1
Total Receivables
141
142
157
170
160
241
307
Accounts Receivables
127
121
134
143
141
221
287
Other Receivables
15
21
23
27
19
20
20
Inventory
188
228
240
238
327
445
510
Other Current Assets
21
17
9
10
8
12
14
Total Current Assets
546
554
665
978
940
1 088
1 366
PP&E Net
229
328
383
507
717
742
987
PP&E Gross
229
328
383
507
717
742
987
Accumulated Depreciation
101
119
167
195
245
306
360
Intangible Assets
33
33
43
42
40
123
121
Long-Term Investments
0
0
0
0
15
55
79
Other Long-Term Assets
8
6
10
6
9
27
21
Total Assets
816
N/A
921
+13%
1 100
+19%
1 533
+39%
1 721
+12%
2 035
+18%
2 575
+26%
Liabilities
Accounts Payable
65
86
73
93
137
115
174
Accrued Liabilities
20
18
19
23
41
42
53
Short-Term Debt
22
9
6
4
0
65
149
Current Portion of Long-Term Debt
0
0
0
0
4
6
5
Other Current Liabilities
22
17
19
21
10
94
120
Total Current Liabilities
129
130
117
142
193
322
501
Long-Term Debt
0
0
0
0
14
16
72
Deferred Income Tax
1
1
2
2
2
5
0
Minority Interest
0
0
0
0
2
8
0
Other Liabilities
3
3
4
4
5
8
34
Total Liabilities
132
N/A
133
+1%
123
-8%
148
+20%
215
+45%
359
+67%
607
+69%
Equity
Common Stock
360
360
360
401
401
406
406
Retained Earnings
78
182
371
495
615
773
999
Additional Paid In Capital
247
247
247
490
492
553
585
Treasury Stock
0
0
0
0
0
57
46
Other Equity
0
1
1
1
1
1
23
Total Equity
684
N/A
788
+15%
977
+24%
1 385
+42%
1 506
+9%
1 676
+11%
1 968
+17%
Total Liabilities & Equity
816
N/A
921
+13%
1 100
+19%
1 533
+39%
1 721
+12%
2 035
+18%
2 575
+26%
Shares Outstanding
Common Shares Outstanding
360
360
360
401
401
401
402

See Also

Discover More